Found 8 matching trials
Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible) PHASE2 To assess the dose-related antiviral effects of SC-48334 and zidovudine (AZ...
Show More Learn More & Join Trial
Study to Evaluate the Safety of AT2220 (Duvoglustat) in Pompe Disease PHASE2 The main purpose of this study was to determine the safety and tolerability...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Mulberry Leaf Extract on Blood Glucose NA The purpose of this study is to evaluate the effect of mulberry leaf extrac...
Show More Location
Bundang CHA Medical Center
Learn More & Join Trial
Effect of Science Research Wellness Ndo1 on Glycaemia in Adults With Pre-diabetes NA The objective of this study is to test the effect of 12 weeks of supplement...
Show More Learn More & Join Trial
Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex PHASE1 To determine the following about the use of SC-48334 in patients with AIDS ...
Show More Location
Univ of California / San Diego Treatment Ctr
Learn More & Join Trial
Drug-drug Interaction Study PHASE2 This study evaluates drug-drug interactions between AT2220 (duvoglustat) an...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy of Milk Product Supplemented With Bioactives in Lowering Post Meal Glucose Response NA This is a monocentric, randomized controlled, open-label, 2x2 cross-over st...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Expanded Access for ATB200/AT2221 for the Treatment of IOPD N/A This is an expanded access program (EAP) for eligible participants designed...
Show More Location
UCSF Benioff Children's Hospital Oakland
Learn More & Join Trial